Gralnick HR, Wright MD, McGinniss MH. Coombs’ positive reactions associated with sodium cephalothin therapy. JAMA 1967;199:725–6.10.1001/jama.1967.03120100087016Search in Google Scholar
Molthan L, Reidenberg MM, Eichmen MF. Positive direct Coombs’ tests due to cephalothin. New Eng J Med 1967:277:123–6.10.1056/NEJM196707202770303Search in Google Scholar
Garratty G, Petz LD. Drug-induced immune hemolytic anemia. Am J Med 1975;58:398–407.10.1016/0002-9343(75)90606-3Search in Google Scholar
Gralnick HR, McGinniss MH, Elton W, McCurdy P. Hemolytic anemia associated with cephalothin. JAMA 1971;217:1193–7.10.1001/jama.1971.03190090015004Search in Google Scholar
Petz LD, Fudenberg HH. Coomb’s-positive hemolytic anemia caused by penicillin administration. New Eng J Med 1966;274:171–7.10.1056/NEJM1966012727404014159252Search in Google Scholar
Swanson MA, Chanmougan D, Schwartz RS. Immunohemolytic anemia due to anti-penicillin antibodies: report of a case. New Eng J Med 1966;274:178–80.10.1056/NEJM1966012727404025902616Search in Google Scholar
Jeannet A, Bloch A, Dayer JM, Farquet JJ, Girard JP, Cruchaud A. Cephalothin-induced immune hemolytic anemia. Acta Haematol (Basel) 1976;55:109–17.10.1159/000208002816141Search in Google Scholar
Moake JL, Butler CF, Hewell GM, Cheek J, Spruel MA. Hemolysis induced by cefazolin and cephalothin in a patient with penicillin sensitivity. Transfusion 1978;18:369–73.10.1046/j.1537-2995.1978.18378205151.x96555Search in Google Scholar
Rubin RN, Burka ER. Anti-cephalothin antibody and Coomb’s positive hemolytic anemia (letter). Ann Intern Med 1977;86:64–5.10.7326/0003-4819-86-1-64299995Search in Google Scholar
Branch DR, Berkowitz LR, Becker RL, et al. Extravascular hemolysis following the administration of cefamandole. Am J Hematol 1985;18:213–9.10.1002/ajh.28301802133970014Search in Google Scholar
Toy E, Nesbitt R, Savastano G, Fox S, Araneta M, Hseuh Y. Warm autoantibody following plasma apheresis, complicated by acute intravascular hemolysis associated with cefoxitin-dependent antibody resulting in fatality (abstract). Transfusion 1989;29(Supp1):51S.Search in Google Scholar
Salama A, Göttsche B, Schleiffer T, Mueller-Eckhardt C. “Immune complex”-mediated intravascular hemolysis due to IgM cephalosporin-dependent antibody. Transfusion 1987;27:460–3.10.1046/j.1537-2995.1987.27688071694.x3500531Search in Google Scholar
Shulman IA, Arndt PA, McGehee W, Garratty G. Cefotaxime-induced immune hemolytic anemia due to antibodies reacting in vitro by more than one mechanism. Transfusion 1990;30:363–6.10.1046/j.1537-2995.1990.30390194351.x2316002Search in Google Scholar
Chambers LA, Donovan LM, Kruskall MS, Pacini DG. Ceftazidime-induced hemolysis in a patient with drug-dependent antibodies reactive by immune complex and drug adsorption mechanisms. Am J Clin Pathol 1991;95:393–6.10.1093/ajcp/95.3.3931996549Search in Google Scholar
Garratty G, Postoway N, Schwellenbach J, McMahill PC. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion 1991;31:176–9.10.1046/j.1537-2995.1991.31291142951.x1825363Search in Google Scholar
Eckrich RJ, Fox S, Mallory D. Cefotetan-induced immune hemolytic anemia due to the drug adsorption mechanism (abstract). Transfusion 1989;29(Suppl):17S.Search in Google Scholar
Weitkamp LA, Johnson ST, Fueger JT, Rucker JT, Shah A, Aster RH. Cefotetan-dependent immune hemolytic anemia due to a single antibody reacting with both drug coated and untreated red cells in the presence of drug (abstract). Book of abstracts of the International Society of Blood Transfusion/American Association of Blood Banks Joint Congress. Los Angeles, CA, November 1990:33.Search in Google Scholar
Gallagher NT, Schergen AK, Sokol-Anderson ML, Sheahan EJ, Chaplin H. Severe immune mediated hemolytic anemia secondary to cefotetan. Transfusion 1992;32:266–8.10.1046/j.1537-2995.1992.32392213812.x1557810Search in Google Scholar
Wojcicki RE, Larson CJ, Pope ME, Sullivan CM. Acute hemolytic anemia during cefotetan therapy (abstract). Book of abstracts of the International Society of Blood Transfusion/American Association of Blood Banks Joint Congress. Los Angeles, CA, November 1990:33.Search in Google Scholar
Ehmann WC. Cephalosporin-induced hemolysis: a case report and review of the literature. Am J Hematol 1992;40:121–5.10.1002/ajh.28304002091585910Search in Google Scholar
Garratty G, Nance S, Lloyd M, Domen R. Fatal immune hemolytic anemia due to cefotetan. Transfusion 1992;32:269–71.10.1046/j.1537-2995.1992.32392213813.x1557811Search in Google Scholar
Peano GM, Menardi G, Quararta L, Abello P, Landra M, Feroglio S. A rapidly fatal case of immune hemolytic anemia due to cefotetan (letter). Vox Sang 1994;66:84–5.10.1111/j.1423-0410.1994.tb00285.x8146991Search in Google Scholar
Marsh WL. Scoring of hemagglutination reactions. Transfusion 1972;12:352–3.10.1111/j.1537-2995.1972.tb04459.x5072588Search in Google Scholar
Garratty G. Laboratory investigation of drug-induced hemolytic anemia. In: Bell CA, ed. A seminar on laboratory management of hemolysis, Washington, DC, 1979(Supplement):1.Search in Google Scholar
Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.10.1046/j.1537-2995.1987.27688071692.x3686653Search in Google Scholar
